SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000950170-24-047247
Filing Date
2024-04-24
Accepted
2024-04-24 07:19:33
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-24

Document Format Files

Seq Description Document Type Size
1 ARS amlx-ars-2024.pdf ARS 4729206
  Complete submission text file 0000950170-24-047247.txt   6513982
Mailing Address 43 THORNDIKE STREET CAMBRIDGE MA 02141
Business Address 43 THORNDIKE STREET CAMBRIDGE MA 02141 617-683-0917
Amylyx Pharmaceuticals, Inc. (Filer) CIK: 0001658551 (see all company filings)

IRS No.: 464600503 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-41199 | Film No.: 24866715
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)